Cargando…

Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study

BACKGROUND: A population-based analysis of the risk of secondary primary malignancy (SPM) in patients with hypopharyngeal carcinoma (HPC) has been lacking in the literature. Therefore, we conducted this study to determine the risk factors and assess the effects of SPM on the overall survival (OS) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Liqing, Fu, Yanpeng, Miao, Chunyu, Wu, Shuhong, Zhu, Yaqiong, Liu, Yuehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630468/
https://www.ncbi.nlm.nih.gov/pubmed/34858052
http://dx.doi.org/10.2147/IJGM.S339595
_version_ 1784607376653942784
author Guo, Liqing
Fu, Yanpeng
Miao, Chunyu
Wu, Shuhong
Zhu, Yaqiong
Liu, Yuehui
author_facet Guo, Liqing
Fu, Yanpeng
Miao, Chunyu
Wu, Shuhong
Zhu, Yaqiong
Liu, Yuehui
author_sort Guo, Liqing
collection PubMed
description BACKGROUND: A population-based analysis of the risk of secondary primary malignancy (SPM) in patients with hypopharyngeal carcinoma (HPC) has been lacking in the literature. Therefore, we conducted this study to determine the risk factors and assess the effects of SPM on the overall survival (OS) and cancer-specific survival (CSS) of patients with HPC. METHODS: Data on selected patients diagnosed with HPC from the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2015 were examined through logistic regression, Cox regression and nomogram methods. RESULTS: The overall risk of SPM in patients with HPC was higher than that in the general population (SIR: 2.77; P < 0.05). The specific-site, including the oral cavity, pharynx, digestive system, respiratory system and endocrine system, had a relatively higher risk of SPM. The overall risks of the subgroup of people 55–75 years of age and all subgroups of sex, race and latency were significantly elevated. In addition, patients with HPC were more likely to have been diagnosed in 2010–2015 (vs 2004–2009; P = 0.002), to be unmarried (vs married; P = 0.008), to have distant metastasis (vs no metastasis; P = 0.016) and to have had no surgery for the first tumor (vs surgery for the first tumor; P = 0.021), and these aspects were associated with a significantly elevated risk of developing SPM. SPM was independently associated with better OS and CSS. The OS and CSS in patients with HPC with SPM were better than those in patients without SPM (log rank P < 0.0001). The C indexes of the nomogram constructed with ten influencing factors including SPM were 0.681:0.699 for OS and 0.705:0.724 for CSS (training cohort:validation cohort). CONCLUSION: Although the overall risk of SPM in patients with HPC was elevated, SPM did not decrease the OS and CSS in patients with HPC. This finding is inconsistent with clinical observations and thus requires further research and exploration. It possibly because HPC might have a shorter survival time, or the follow-up time was not long enough.
format Online
Article
Text
id pubmed-8630468
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86304682021-12-01 Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study Guo, Liqing Fu, Yanpeng Miao, Chunyu Wu, Shuhong Zhu, Yaqiong Liu, Yuehui Int J Gen Med Original Research BACKGROUND: A population-based analysis of the risk of secondary primary malignancy (SPM) in patients with hypopharyngeal carcinoma (HPC) has been lacking in the literature. Therefore, we conducted this study to determine the risk factors and assess the effects of SPM on the overall survival (OS) and cancer-specific survival (CSS) of patients with HPC. METHODS: Data on selected patients diagnosed with HPC from the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2015 were examined through logistic regression, Cox regression and nomogram methods. RESULTS: The overall risk of SPM in patients with HPC was higher than that in the general population (SIR: 2.77; P < 0.05). The specific-site, including the oral cavity, pharynx, digestive system, respiratory system and endocrine system, had a relatively higher risk of SPM. The overall risks of the subgroup of people 55–75 years of age and all subgroups of sex, race and latency were significantly elevated. In addition, patients with HPC were more likely to have been diagnosed in 2010–2015 (vs 2004–2009; P = 0.002), to be unmarried (vs married; P = 0.008), to have distant metastasis (vs no metastasis; P = 0.016) and to have had no surgery for the first tumor (vs surgery for the first tumor; P = 0.021), and these aspects were associated with a significantly elevated risk of developing SPM. SPM was independently associated with better OS and CSS. The OS and CSS in patients with HPC with SPM were better than those in patients without SPM (log rank P < 0.0001). The C indexes of the nomogram constructed with ten influencing factors including SPM were 0.681:0.699 for OS and 0.705:0.724 for CSS (training cohort:validation cohort). CONCLUSION: Although the overall risk of SPM in patients with HPC was elevated, SPM did not decrease the OS and CSS in patients with HPC. This finding is inconsistent with clinical observations and thus requires further research and exploration. It possibly because HPC might have a shorter survival time, or the follow-up time was not long enough. Dove 2021-11-25 /pmc/articles/PMC8630468/ /pubmed/34858052 http://dx.doi.org/10.2147/IJGM.S339595 Text en © 2021 Guo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Guo, Liqing
Fu, Yanpeng
Miao, Chunyu
Wu, Shuhong
Zhu, Yaqiong
Liu, Yuehui
Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
title Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
title_full Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
title_fullStr Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
title_full_unstemmed Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
title_short Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
title_sort second primary malignancy in patients with hypopharyngeal carcinoma: a seer-based study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630468/
https://www.ncbi.nlm.nih.gov/pubmed/34858052
http://dx.doi.org/10.2147/IJGM.S339595
work_keys_str_mv AT guoliqing secondprimarymalignancyinpatientswithhypopharyngealcarcinomaaseerbasedstudy
AT fuyanpeng secondprimarymalignancyinpatientswithhypopharyngealcarcinomaaseerbasedstudy
AT miaochunyu secondprimarymalignancyinpatientswithhypopharyngealcarcinomaaseerbasedstudy
AT wushuhong secondprimarymalignancyinpatientswithhypopharyngealcarcinomaaseerbasedstudy
AT zhuyaqiong secondprimarymalignancyinpatientswithhypopharyngealcarcinomaaseerbasedstudy
AT liuyuehui secondprimarymalignancyinpatientswithhypopharyngealcarcinomaaseerbasedstudy